Epidemiological open-label study to evaluate the frequency of helicobacter Pylori infections prior to and after equimolar switch from therapy with MMF to enteric-coated Mycophenolic Acid (MYFORTIC-ERL080) in stable renal transplant patients

• Conditions: Profilaxis of rejection in stable renal transplant patients; MedDRA version: 6.1Level: PTClassification code 10046694

• Registration Number: EUCTR2004-002973-22-IT
• Lead Sponsor: AZIENDA UNIVERSITARIA OSPEDALE POLICLINICO UMBERTO I

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-08-01
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: ;Secondary Objective: ;Primary end point(s):